Reversible Immunoaffinity Interface Enables Dynamic Manipulation of Trapping Force for Accumulated Capture and Efficient Release of Circulating Rare Cells.
Reversible Immunoaffinity Interface Enables Dynamic Manipulation of Trapping Force for Accumulated Capture and Efficient Release of Circulating Rare Cells.
复制标题
可逆免疫亲和界面可动态操纵捕获力,以累积捕获和有效释放循环稀有细胞
DOI:
10.1002/advs.202102070
复制
发表时间:
2021-10
期刊:
影响因子:
--
通讯作者:
Yang C
中科院分区:
文献类型:
--
作者:
Chen X;Ding H;Zhang D;Zhao K;Gao J;Lin B;Huang C;Song Y;Zhao G;Ma Y;Wu L;Yang C
Controllable assembly and disassembly of recognition interface are vital for bioanalysis. Herein, a strategy of dynamic manipulation of trapping force by engineering a dynamic and reversible immunoaffinity microinterface (DynarFace) in a herringbone chip (DynarFace‐Chip) for liquid biopsy is proposed. The DynarFace is assembled by magnetically attracting immunomagnetic beads (IMBs) on chip substrate, with merits of convenient operation and reversible assembly. The DynarFace allows accumulating attachment of IMBs on circulating rare cell (CRC) surfaces during hydrodynamically enhanced interface collision, where accumulatively enhanced magnetic trapping force improves capture efficiency toward CRCs with medium expression of biomarkers from blood samples by 134.81% compared with traditional non‐dynamic interfaces. Moreover, magnet withdrawing‐induced disappearance of trapping force affords DynarFace disassembly and CRC release with high efficiency (>98%) and high viability (≈98%), compatible with downstream in vitro culture and gene analysis of CRCs. This DynarFace strategy opens a new avenue to accumulated capture and reversible release of CRCs, holding great potential for liquid biopsy‐based precision medicine. A dynamic and reversible immunoaffinity microinterface is engineered in a microfluidic chip, with merits of easy operation and reversible assembly. It enables dynamic manipulation of trapping force for accumulated capture and reversible release of circulating rare cells, holding great potential in liquid biopsy‐based precision medicine.
登录
查看更多内容
影响因子:
6.1
作者:
Sheng W;Ogunwobi OO;Chen T;Zhang J;George TJ;Liu C;Fan ZH
通讯作者:
Fan ZH
影响因子:
16.6
作者:
Chen, Kangfu;Dopico, Pablo;Fan, Z. Hugh
通讯作者:
Fan, Z. Hugh
影响因子:
14
作者:
Ding, Hong-ming;Ma, Yu-qiang
通讯作者:
Ma, Yu-qiang
影响因子:
17.1
作者:
Wen, Cong-Ying;Wu, Ling-Ling;Pang, Dai-Wen
通讯作者:
Pang, Dai-Wen
影响因子:
7.4
作者:
Tang, Man;Xia, Hou-Fu;Zhang, Zhi-Ling
通讯作者:
Zhang, Zhi-Ling